BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 7748047)

  • 21. Assessment of interchangeability of two brands of levothyroxine preparations with a third-generation TSH assay.
    Escalante DA; Arem N; Arem R
    Am J Med; 1995 Apr; 98(4):374-8. PubMed ID: 7709950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levothyroxine replacement therapy after thyroid surgery.
    Verhaert N; Vander Poorten V; Delaere P; Bex M; Debruyne F
    B-ENT; 2006; 2(3):129-33. PubMed ID: 17067083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment.
    Parle JV; Franklyn JA; Cross KW; Jones SR; Sheppard MC
    Br J Gen Pract; 1993 Mar; 43(368):107-9. PubMed ID: 8323787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperthyroxinemia in patients receiving thyroid replacement therapy.
    Grund FM; Niewoehner CB
    Arch Intern Med; 1989 Apr; 149(4):921-4. PubMed ID: 2705841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hypothyroidism with L-thyroxine].
    Zgliczyńska-Widłak J
    Pol Tyg Lek; 1993 Jul 5-12; 48(27-28):605-8. PubMed ID: 8090652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy?
    Chopra IJ; Baber K
    Metabolism; 2003 Jan; 52(1):122-8. PubMed ID: 12524672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial.
    Bolk N; Visser TJ; Nijman J; Jongste IJ; Tijssen JG; Berghout A
    Arch Intern Med; 2010 Dec; 170(22):1996-2003. PubMed ID: 21149757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a sensitive thyrotropin-stimulating hormone assay on dosing of L-thyroxine.
    Drinka P; Schomisch G; Depka C; Deterville R; Nickel D; Voeks S
    Wis Med J; 1991 Aug; 90(8):468-9. PubMed ID: 1926886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial.
    Valizadeh M; Seyyed-Majidi MR; Hajibeigloo H; Momtazi S; Musavinasab N; Hayatbakhsh MR
    Endocr Res; 2009; 34(3):80-9. PubMed ID: 19701833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders.
    Csako G; McGriff NJ; Rotman-Pikielny P; Sarlis NJ; Pucino F
    Ann Pharmacother; 2001 Dec; 35(12):1578-83. PubMed ID: 11793625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism.
    Abalovich M; Alcaraz G; Kleiman-Rubinsztein J; Pavlove MM; Cornelio C; Levalle O; Gutierrez S
    Thyroid; 2010 Oct; 20(10):1175-8. PubMed ID: 20860419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting thyroxine requirements following total thyroidectomy.
    Mistry D; Atkin S; Atkinson H; Gunasekaran S; Sylvester D; Rigby AS; England RJ
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):384-7. PubMed ID: 21198738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical utility of serum T3 measurement in patients with primary hypothyroidism undergoing therapy with l-thyroxine].
    Aguayo J; Silva R; Pineda G
    Rev Med Chil; 1984 Dec; 112(12):1201-5. PubMed ID: 6537614
    [No Abstract]   [Full Text] [Related]  

  • 35. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
    Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
    J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.
    Appelhof BC; Fliers E; Wekking EM; Schene AH; Huyser J; Tijssen JG; Endert E; van Weert HC; Wiersinga WM
    J Clin Endocrinol Metab; 2005 May; 90(5):2666-74. PubMed ID: 15705921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noncompliance with medical treatment: pseudomalabsorption of levothyroxine.
    Eledrisi MS; Szymajda A; Alshanti M; Urban RJ
    South Med J; 2001 Aug; 94(8):833-6. PubMed ID: 11549198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
    Green WL
    AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of elevated serum thyrotropin during treatment of congenital hypothyroidism.
    Heyerdahl S; Kase BF
    Acta Paediatr; 1995 Jun; 84(6):634-8. PubMed ID: 7670245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.
    Benvenga S; Di Bari F; Vita R
    Endocrine; 2017 Apr; 56(1):138-145. PubMed ID: 28155174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.